Skip to main content
. 2014 Jul 7;32(23):2496–2502. doi: 10.1200/JCO.2013.53.5724

Table 1.

Demographic and Medical Characteristics of Participants

Characteristic All Patients
UC Group
AT Group
P
No. % Mean SD No. % Mean SD No. % Mean SD
No. of patients 90 100 43 48 47 52
Age, years 66 11 66 11 66 10 .861
Female sex 23 26 10 23 13 28 .632
Weight, kg 85.1 19.8 86.6 21.7 83.8 18.2 .507
BMI, kg/m2 28 6 29 8 28 5 .385
Heart rate, beats · min–1 71 11 72 11 70 11 .269
Systolic blood pressure, mmHg 116 19 117 20 115 18 .634
Diastolic blood pressure, mmHg 70 10 69 9 70 11 .422
NYHA class .344
    II 57 63 29 67 28 60
    III 31 34 14 33 17 36
    IV 2 2 0 0 2 4
Race/ethnicity .810
    White 59 66 28 65 31 67
    African American 27 30 14 33 13 28
    Other 3 3 1 2 2 4
Left ventricular ejection fraction, % 26 8 27 8 24 8 .188
Comorbid conditions
    Diabetes 34 38 19 44 15 32 .230
    Previous MI 44 49 18 42 26 55 .202
    Hypertension 52 58 28 65 24 51 .177
    Atrial fibrillation or atrial flutter 18 20 7 16 11 23 .398
Sodium 139.5 2.7 139.5 2.9 139.4 2.4 .941
Serum creatinine 1.5 1.3 1.4 0.5 1.6 1.8 .353
Medications and devices
    ACE inhibitor or ARB 85 94 40 93 45 96 .573
    Beta blocker 79 88 41 95 38 81 .036
    Aldosterone 34 38 13 30 21 45 .157
    Loop diuretic 65 72 33 77 32 68 .359
    Digoxin 44 49 19 44 25 53 .393
    Implantable cardioverter-defibrillator 35 39 15 35 20 43 .456
    Biventricular pacemaker 16 18 8 19 8 17 .844

NOTE. Continuous variables are reported as mean and standard deviation (SD); categorical variables are reported as No. and %.

Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blocker; AT, aerobic training; BMI, body mass index; MI, myocardial infarction; NYHA, New York Heart Association; UC, usual care.